CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
ASSETS
Cash and cash equivalents	$ 23,035	$ 28,301
Investments:
Fixed maturities, available-for-sale, at fair value (amortized cost: $237,207 and $238,626; no allowance for credit losses)	221,696	218,219
Equity securities, at fair value (cost: $4,940 and $4,936)	7,800	9,413
Other invested assets (cost: $9,300 and $6,982)	8,205	6,381
Policy loans	1,738	1,778
Real estate	38	38
Investment in unconsolidated trusts	1,238	1,238
Total investments	240,715	237,067
Receivables:
Reinsurance (net of allowance for expected credit losses of $53 and $61)	21,600	21,103
Insurance premiums and other (net of allowance for expected credit losses of $215 and $217)	30,492	23,690
Deferred income taxes, net	16,079	15,682
Deferred acquisition costs	44,284	43,850
Other assets	8,240	9,028
Intangibles	2,544	2,544
Total assets	386,989	381,265
Insurance reserves and policyholder funds:
Future policy benefits	97,077	92,495
Unearned premiums	28,972	31,317
Losses and claims	91,864	87,478
Other policy liabilities	969	1,132
Total insurance reserves and policyholder funds	218,882	212,422
Accounts payable and accrued expenses	24,586	24,811
Revolving credit facility	4,024	3,019
Junior subordinated debenture obligations, net	33,738	33,738
Total liabilities	281,230	273,990
Commitments and contingencies (Notes 3 and 12)
Shareholders' equity:
Preferred stock, $1 par, 4,000,000 shares authorized; Series D preferred, 55,000 shares issued and outstanding; $5,500 redemption value	55	55
Common stock, $1 par, 50,000,000 shares authorized; shares issued: 22,400,894; shares outstanding: 20,399,758 and 20,402,288	22,401	22,401
Additional paid-in capital	57,425	57,425
Retained earnings	45,543	50,929
Accumulated other comprehensive loss	(12,253)	(16,121)
Unearned stock grant compensation	(4)	(13)
Treasury stock, at cost: 2,001,136 and 1,998,606 shares	(7,408)	(7,401)
Total shareholders' equity	105,759	107,275
Total liabilities and shareholders' equity	$ 386,989	$ 381,265